|
EP2305812A3
(en)
|
2002-11-14 |
2012-06-06 |
Dharmacon, Inc. |
Fuctional and hyperfunctional sirna
|
|
US7514530B2
(en)
|
2004-04-26 |
2009-04-07 |
Centre National De La Recherche Scientifique |
Peptide carrier for delivering siRNA into mammalian cells
|
|
US7579318B2
(en)
|
2005-12-06 |
2009-08-25 |
Centre De La Recherche De La Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
|
EP4032552B1
(en)
|
2008-08-26 |
2023-10-04 |
City of Hope |
Method and compositions for enhanced anti-tumor effector functioning of t cells
|
|
US8889394B2
(en)
|
2009-09-07 |
2014-11-18 |
Empire Technology Development Llc |
Multiple domain proteins
|
|
DK2631291T3
(da)
|
2010-10-22 |
2019-06-11 |
Olix Pharmaceuticals Inc |
Nukleinsyremolekyler, der inducerer rna-interferens, og anvendelser deraf
|
|
US20140065615A1
(en)
|
2011-03-21 |
2014-03-06 |
Yale University |
The KRAS Variant and Tumor Biology
|
|
WO2012137036A1
(en)
|
2011-04-04 |
2012-10-11 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
|
EP2782926B1
(en)
*
|
2011-11-24 |
2018-07-04 |
Positec Power Tools (Suzhou) Co., Ltd |
Peptide sequence design and use thereof for peptide-mediated sirna delivery
|
|
JP2013212052A
(ja)
|
2012-03-30 |
2013-10-17 |
Yale Univ |
Ｋｒａｓバリアントおよび腫瘍生物学
|
|
AU2013243948A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins associated with human disease
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
WO2013150338A1
(en)
|
2012-04-04 |
2013-10-10 |
Centre National De La Recherche Scientifique |
Stapled cell penetrating peptides for intracellular delivery of molecules
|
|
EA033110B1
(ru)
|
2012-04-11 |
2019-08-30 |
Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез |
Химерный рецептор антигена, направленный на антиген созревания b-клеток, кодирующая его нуклеиновая кислота, соответствующие экспрессионный вектор, клетка-хозяин, применения и способы
|
|
ES2981865T3
(es)
*
|
2012-07-11 |
2024-10-10 |
Gemvax & Kael Co Ltd |
Conjugado que comprende un péptido de penetración celular y composiciones que comprenden el mismo
|
|
SG11201502954TA
(en)
|
2012-07-16 |
2015-05-28 |
Kyowa Hakko Kirin Co Ltd |
Rnai pharmaceutical composition for suppressing expression of kras gene
|
|
WO2014053881A1
(en)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
|
WO2014053879A1
(en)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
|
WO2014053882A1
(en)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
|
WO2014053880A1
(en)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
|
WO2014099671A1
(en)
|
2012-12-20 |
2014-06-26 |
Bluebird Bio, Inc. |
Chimeric antigen receptors and immune cells targeting b cell malignancies
|
|
ITRM20130054A1
(it)
|
2013-01-30 |
2014-07-31 |
Paolo Gresele |
Piastrine trasfettate con materiale genetico esogeno e microparticelle derivate da dette piastrine trasfettate, metodo per la loro preparazione e loro usi.
|
|
EP4303232A3
(en)
|
2013-02-15 |
2024-04-17 |
The Regents of The University of California |
Chimeric antigen receptor and methods of use thereof
|
|
EP3237436B1
(en)
*
|
2014-12-24 |
2019-05-01 |
Aadigen, Llc |
Peptides and nanoparticles for intracellular delivery of molecules
|
|
EP3444345B1
(en)
|
2016-04-14 |
2024-07-10 |
e-NA Biotec Inc. |
microRNA-143 DERIVATIVE
|
|
US20190211317A1
(en)
|
2016-05-27 |
2019-07-11 |
Aadigen, Llc |
Peptides and nanoparticles for intracellular delivery of genome-editing molecules
|
|
AU2017268842B2
(en)
*
|
2016-05-27 |
2022-08-11 |
Aadigen, Llc |
Peptides and nanoparticles for intracellular delivery of genome-editing molecules
|
|
EP3665285A4
(en)
*
|
2017-08-10 |
2021-08-11 |
Aadigen, LLC |
PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR VIRUS ADMINISTRATION
|
|
US20200323964A1
(en)
|
2017-10-16 |
2020-10-15 |
Aadigen, Llc |
Peptides and nanoparticles for intracellular delivery of mrna
|
|
MX2021012740A
(es)
|
2019-04-17 |
2022-01-24 |
Aadigen Llc |
Péptidos y nanopartículas para entrega intracelular de moléculas.
|
|
CA3181170A1
(en)
|
2020-04-24 |
2021-10-28 |
Aadigen, Llc |
Compositions for treating cancer with kras mutations and uses thereof
|
|
CN116724059A
(zh)
|
2020-07-24 |
2023-09-08 |
阿迪根有限公司 |
用于治疗病毒感染的组合物和方法
|